Drug Profile
SLV 322
Alternative Names: SLV322Latest Information Update: 18 Jul 2007
Price :
$50
*
At a glance
- Originator Solvay
- Class Antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 06 May 2005 This compound is still in active development
- 26 Aug 2003 Preclinical trials in Arrhythmias in USA (unspecified route)